CLX

The Clorox Company

Consumer DefensiveHousehold & Personal ProductsNASDAQ

$90.02

-$4.87 (-5.41%)today

Conviction

6/ 10

Fair Value$121.41

Upside+34.87%

Signal20.92

Market Cap$12.6B

52W Range$96.66–$143.96

Next EarningsMay 5

Conviction History

Conviction Changes

Mar 18, 2026, 7:04 PM5→6conviction-rescore

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$131.20

Current Price$102.04

Upside / Down+28.6%

P(Undervalued)85.5%

P(20%+ Up)61.9%

P(15%+ Down)3.8%

Fair Value Distribution — percentile bands

85.5% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-3.7%/yr

±3.9% · revenue growth to justify current price

FCF-Based Reverse DCF

-1.5%/yr

±3.2% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10qMar 4

Conviction: unchanged

CLX 10-Q: Margin Compression Amid ERP Transition, GOJO Acquisition on the Horizon

CLX 10-Q shows revenue down 10% (ERP transition + lower consumption) with gross margin down 230 bps from cost inflation. EBIT declined 26% in 6M as volume deleverage overwhelmed cost actions. GOJO acq...